Skip to main content
Top
Published in: Journal of General Internal Medicine 10/2016

01-10-2016 | Original Research

BMI Trajectories as a Harbinger of Pre-Diabetes or Underdiagnosed Diabetes: an 18-Year Retrospective Cohort Study in Taiwan

Authors: Ching-Ju Chiu, PhD, Siao-Ling Li, MS, Chih-Hsing Wu, MD, Ye-Fong Du, MD

Published in: Journal of General Internal Medicine | Issue 10/2016

Login to get access

Abstract

Background

Although prior studies have examined BMI trajectories in Western populations, little is known regarding how BMI trajectories in Asian populations vary between adults with and without diabetes.

Objective

To examine how BMI trajectories vary between those developing and not developing diabetes over 18 years in an Asian cohort.

Design

Multilevel modeling was used to depict levels and rates of change in BMI for up to 18 years for participants with and without self-reported physician-diagnosed diabetes.

Participants

We used 14,490 data points available from repeated measurements of 3776 participants aged 50+ at baseline without diabetes from a nationally representative survey of the Taiwan Longitudinal Study on Aging (TLSA1989-2007).

Main Measures

We defined development of diabetes as participants who first reported diabetes diagnoses in 2007 but had no diabetes diagnoses at baseline. We defined the reference group as those participants who reported the absence of diabetes at baseline and during the entire follow-up period.

Key Results

When adjusted for time-varying comorbidities and behavioral factors, higher level and constant increases in BMI were present more than 6.5 years before self-reported diabetes diagnosis. The higher BMI level associating with the development of diabetes was especially evident in females. Within 6.5 years prior to self-reported diagnosis, however, a wider range of decreases in BMI occurred (βdiabetes = 1.294, P = 0.0064; βdiabetes*time = 0.150, P = 0.0327; βdiabetes*time 2 = −0.008, P = 0.0065). The faster rate of increases in BMI followed by a greater decline was especially prominent in males and individuals with BMI ≧24.

Conclusions

An unintentional decrease in BMI in sharp contrast to the gradually rising BMI preceding that time may be an alarm for undiagnosed diabetes or a precursor to developing diabetes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4–14.CrossRefPubMed Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4–14.CrossRefPubMed
2.
go back to reference Harris MI, Eastman RC. Early detection of undiagnosed diabetes mellitus: a US perspective. Diabetes Metab Res Rev. 2000;16(4):230–236.CrossRefPubMed Harris MI, Eastman RC. Early detection of undiagnosed diabetes mellitus: a US perspective. Diabetes Metab Res Rev. 2000;16(4):230–236.CrossRefPubMed
3.
go back to reference American Diabetes Association. 2. Classification and diagnosis of diabetes. Diabetes Care. 2016;39 Suppl 1:S13-22. American Diabetes Association. 2. Classification and diagnosis of diabetes. Diabetes Care. 2016;39 Suppl 1:S13-22.
4.
go back to reference Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4–7 yr before clinical diagnosis. Diabetes Care. 1992;15(7):815–819.CrossRefPubMed Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4–7 yr before clinical diagnosis. Diabetes Care. 1992;15(7):815–819.CrossRefPubMed
5.
go back to reference Rathmann W, Haastert B. Icks AA, et al. High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000. Diabetologia. 2003;46(2):182–189.PubMed Rathmann W, Haastert B. Icks AA, et al. High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000. Diabetologia. 2003;46(2):182–189.PubMed
6.
go back to reference Looker HC, Knowler WC, Hanson RL. Changes in BMI and weight before and after the development of type 2 diabetes. Diabetes Care. 2001;24(11):1917–1922.CrossRefPubMed Looker HC, Knowler WC, Hanson RL. Changes in BMI and weight before and after the development of type 2 diabetes. Diabetes Care. 2001;24(11):1917–1922.CrossRefPubMed
7.
go back to reference de Fine Olivarius N, Richelsen B, Siersma V, Andreasen AH, Beck-Nielsen H. Weight history of patients with newly diagnosed type 2 diabetes. Diabet Med. 2008;25(8):933–941.CrossRefPubMed de Fine Olivarius N, Richelsen B, Siersma V, Andreasen AH, Beck-Nielsen H. Weight history of patients with newly diagnosed type 2 diabetes. Diabet Med. 2008;25(8):933–941.CrossRefPubMed
8.
go back to reference de Fine ON, Siersma VD, Koster-Rasmussen R, Heitmann BL, Waldorff FB. Weight changes following the diagnosis of type 2 diabetes: the impact of recent and past weight history before diagnosis. results from the Danish Diabetes Care in General Practice (DCGP) study. PLoS One. 2015;10(4):e0122219.CrossRef de Fine ON, Siersma VD, Koster-Rasmussen R, Heitmann BL, Waldorff FB. Weight changes following the diagnosis of type 2 diabetes: the impact of recent and past weight history before diagnosis. results from the Danish Diabetes Care in General Practice (DCGP) study. PLoS One. 2015;10(4):e0122219.CrossRef
9.
go back to reference Huxley R, James W, Barzi F, et al. Ethnic comparisons of the cross‐sectional relationships between measures of body size with diabetes and hypertension. Obes Rev. 2008;9(s1):53–61.CrossRefPubMed Huxley R, James W, Barzi F, et al. Ethnic comparisons of the cross‐sectional relationships between measures of body size with diabetes and hypertension. Obes Rev. 2008;9(s1):53–61.CrossRefPubMed
10.
go back to reference Jee SH, Sull JW, Park J, et al. Body-mass index and mortality in Korean men and women. N Engl J Med. 2006;355(8):779–787.CrossRefPubMed Jee SH, Sull JW, Park J, et al. Body-mass index and mortality in Korean men and women. N Engl J Med. 2006;355(8):779–787.CrossRefPubMed
11.
go back to reference Gu D, He J, Duan X, et al. Body weight and mortality among men and women in China. JAMA. 2006;295(7):776–783.CrossRefPubMed Gu D, He J, Duan X, et al. Body weight and mortality among men and women in China. JAMA. 2006;295(7):776–783.CrossRefPubMed
12.
go back to reference King GL, McNeely MJ, Thorpe LE, et al. Understanding and addressing unique needs of diabetes in Asian Americans, native Hawaiians, and Pacific Islanders. Diabetes Care. 2012;35(5):1181–1188.CrossRefPubMedPubMedCentral King GL, McNeely MJ, Thorpe LE, et al. Understanding and addressing unique needs of diabetes in Asian Americans, native Hawaiians, and Pacific Islanders. Diabetes Care. 2012;35(5):1181–1188.CrossRefPubMedPubMedCentral
13.
go back to reference Hsu WC, Araneta MR, Kanaya AM, Chiang JL, Fujimoto W. BMI cut points to identify at-risk Asian Americans for type 2 diabetes screening. Diabetes Care. 2015;38(1):150–158.CrossRefPubMed Hsu WC, Araneta MR, Kanaya AM, Chiang JL, Fujimoto W. BMI cut points to identify at-risk Asian Americans for type 2 diabetes screening. Diabetes Care. 2015;38(1):150–158.CrossRefPubMed
14.
go back to reference Chiu C-J, Wray LA, Ofstedal MB. Diabetes-related change in physical disability from midlife to older adulthood: Evidence from 1996–2003 Survey of Health and Living Status of the Elderly in Taiwan. Diabetes Res Clin Pract. 2011;91(3):413–423.CrossRefPubMed Chiu C-J, Wray LA, Ofstedal MB. Diabetes-related change in physical disability from midlife to older adulthood: Evidence from 1996–2003 Survey of Health and Living Status of the Elderly in Taiwan. Diabetes Res Clin Pract. 2011;91(3):413–423.CrossRefPubMed
15.
go back to reference Raudenbush SW, Bryk AS. Hierarchical linear models: applications and data analysis methods. Sage. 2002. 1. Raudenbush SW, Bryk AS. Hierarchical linear models: applications and data analysis methods. Sage. 2002. 1.
17.
go back to reference Koh-Banerjee P, Wang Y, Hu FB, Spiegelman D, Willett WC, Rimm EB. Changes in body weight and body fat distribution as risk factors for clinical diabetes in US men. Am J Epidemiol. 2004;159(12):1150–1159.CrossRefPubMed Koh-Banerjee P, Wang Y, Hu FB, Spiegelman D, Willett WC, Rimm EB. Changes in body weight and body fat distribution as risk factors for clinical diabetes in US men. Am J Epidemiol. 2004;159(12):1150–1159.CrossRefPubMed
18.
go back to reference Power C, Thomas C. Changes in BMI, duration of overweight and obesity, and glucose metabolism: 45 years of follow-up of a birth cohort. Diabetes Care. 2011;34(9):1986–1991.CrossRefPubMedPubMedCentral Power C, Thomas C. Changes in BMI, duration of overweight and obesity, and glucose metabolism: 45 years of follow-up of a birth cohort. Diabetes Care. 2011;34(9):1986–1991.CrossRefPubMedPubMedCentral
19.
go back to reference Nanri A, Mizoue T, Takahashi Y, et al. Association of weight change in different periods of adulthood with risk of type 2 diabetes in Japanese men and women: the Japan Public Health Center-Based Prospective Study. J Epidemiol Community Health. 2011;65(12):1104–1110.CrossRefPubMed Nanri A, Mizoue T, Takahashi Y, et al. Association of weight change in different periods of adulthood with risk of type 2 diabetes in Japanese men and women: the Japan Public Health Center-Based Prospective Study. J Epidemiol Community Health. 2011;65(12):1104–1110.CrossRefPubMed
20.
go back to reference Wannamethee SG, Shaper AG, Walker M. Overweight and obesity and weight change in middle aged men: impact on cardiovascular disease and diabetes. J Epidemiol Community Health. 2005;59(2):134–139.CrossRefPubMedPubMedCentral Wannamethee SG, Shaper AG, Walker M. Overweight and obesity and weight change in middle aged men: impact on cardiovascular disease and diabetes. J Epidemiol Community Health. 2005;59(2):134–139.CrossRefPubMedPubMedCentral
21.
go back to reference Resnick HE, Valsania P, Halter JB, Lin X. Relation of weight gain and weight loss on subsequent diabetes risk in overweight adults. J Epidemiol Community Health. 2000;54(8):596–602.CrossRefPubMedPubMedCentral Resnick HE, Valsania P, Halter JB, Lin X. Relation of weight gain and weight loss on subsequent diabetes risk in overweight adults. J Epidemiol Community Health. 2000;54(8):596–602.CrossRefPubMedPubMedCentral
22.
go back to reference Hwang L-C, Chen C-J, Lin BJ. Obesity and changes in body weight related to 10-year diabetes incidence in women in Taiwan (1993-2003). Asia Pac J Clin Nutr. 2007;16(4):677–682.PubMed Hwang L-C, Chen C-J, Lin BJ. Obesity and changes in body weight related to 10-year diabetes incidence in women in Taiwan (1993-2003). Asia Pac J Clin Nutr. 2007;16(4):677–682.PubMed
23.
go back to reference Biggs ML, Mukamal KJ, Luchsinger JA, et al. Association between adiposity in midlife and older age and risk of diabetes in older adults. JAMA. 2010;303(24):2504–2512.CrossRefPubMedPubMedCentral Biggs ML, Mukamal KJ, Luchsinger JA, et al. Association between adiposity in midlife and older age and risk of diabetes in older adults. JAMA. 2010;303(24):2504–2512.CrossRefPubMedPubMedCentral
24.
go back to reference Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med. 1995;122(7):481–486.CrossRefPubMed Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med. 1995;122(7):481–486.CrossRefPubMed
25.
go back to reference Schienkiewitz A, Schulze MB, Hoffmann K, Kroke A, Boeing H. Body mass index history and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)–Potsdam Study. Am J Clin Nutr. 2006;84(2):427–433.PubMed Schienkiewitz A, Schulze MB, Hoffmann K, Kroke A, Boeing H. Body mass index history and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)–Potsdam Study. Am J Clin Nutr. 2006;84(2):427–433.PubMed
26.
go back to reference Oguma Y, Sesso HD, Paffenbarger RS, Lee IM. Weight change and risk of developing type 2 diabetes. Obes Res. 2005;13(5):945–951.CrossRefPubMed Oguma Y, Sesso HD, Paffenbarger RS, Lee IM. Weight change and risk of developing type 2 diabetes. Obes Res. 2005;13(5):945–951.CrossRefPubMed
27.
go back to reference Gazewood JD, Mehr DR. Diagnosis and management of weight loss in the elderly. J Fam Pract. 1998;47(1):19–25.PubMed Gazewood JD, Mehr DR. Diagnosis and management of weight loss in the elderly. J Fam Pract. 1998;47(1):19–25.PubMed
28.
go back to reference Williamson DF. Descriptive epidemiology of body weight and weight change in US adults. Ann Intern Med. 1993;119(7_Part_2):646–649.CrossRefPubMed Williamson DF. Descriptive epidemiology of body weight and weight change in US adults. Ann Intern Med. 1993;119(7_Part_2):646–649.CrossRefPubMed
29.
go back to reference Tabák AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimäki M, Witte DR. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet. 2009;373(9682):2215–2221.CrossRefPubMedPubMedCentral Tabák AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimäki M, Witte DR. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet. 2009;373(9682):2215–2221.CrossRefPubMedPubMedCentral
30.
31.
32.
go back to reference Chiu C-J, Wray LA, Lu F-H, Beverly EA. BMI change patterns and disability development of middle-aged adults with diabetes: a dual trajectory modeling approach. J Gen Intern Med. 2013;28(9):1150–1156.CrossRefPubMedPubMedCentral Chiu C-J, Wray LA, Lu F-H, Beverly EA. BMI change patterns and disability development of middle-aged adults with diabetes: a dual trajectory modeling approach. J Gen Intern Med. 2013;28(9):1150–1156.CrossRefPubMedPubMedCentral
33.
go back to reference Sairenchi T, Iso H, Irie F, Fukasawa N, Ota H, Muto T. Underweight as a predictor of diabetes in older adults a large cohort study. Diabetes Care. 2008;31(3):583–584.CrossRefPubMed Sairenchi T, Iso H, Irie F, Fukasawa N, Ota H, Muto T. Underweight as a predictor of diabetes in older adults a large cohort study. Diabetes Care. 2008;31(3):583–584.CrossRefPubMed
34.
go back to reference Vistisen D, Witte DR, Tabák AG, et al. Patterns of obesity development before the diagnosis of type 2 diabetes: the Whitehall II cohort study. PLoS Med. 2014;11(2):e1001602.CrossRefPubMedPubMedCentral Vistisen D, Witte DR, Tabák AG, et al. Patterns of obesity development before the diagnosis of type 2 diabetes: the Whitehall II cohort study. PLoS Med. 2014;11(2):e1001602.CrossRefPubMedPubMedCentral
35.
go back to reference Goldman N, Lin I-F, Weinstein M, Lin Y-H. Evaluating the quality of self-reports of hypertension and diabetes. J Clin Epidemiol. 2003;56(2):148–154.CrossRefPubMed Goldman N, Lin I-F, Weinstein M, Lin Y-H. Evaluating the quality of self-reports of hypertension and diabetes. J Clin Epidemiol. 2003;56(2):148–154.CrossRefPubMed
36.
go back to reference McAdams MA, Dam RM, Hu FB. Comparison of self‐reported and measured BMI as correlates of disease markers in US adults. Obesity. 2007;15(1):188.CrossRefPubMed McAdams MA, Dam RM, Hu FB. Comparison of self‐reported and measured BMI as correlates of disease markers in US adults. Obesity. 2007;15(1):188.CrossRefPubMed
Metadata
Title
BMI Trajectories as a Harbinger of Pre-Diabetes or Underdiagnosed Diabetes: an 18-Year Retrospective Cohort Study in Taiwan
Authors
Ching-Ju Chiu, PhD
Siao-Ling Li, MS
Chih-Hsing Wu, MD
Ye-Fong Du, MD
Publication date
01-10-2016
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 10/2016
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-016-3750-y

Other articles of this Issue 10/2016

Journal of General Internal Medicine 10/2016 Go to the issue

Healing Arts: Materia Medica

Dressed for the Party

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine